-
公开(公告)号:DK1027361T3
公开(公告)日:2003-08-25
申请号:DK98956314
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , GRIESGRABER GEORGE , CHU DANIEL T , LI LEPING
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
公开(公告)号:AT239750T
公开(公告)日:2003-05-15
申请号:AT98956314
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , GRIESGRABER GEORGE , LI LEPING , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
公开(公告)号:CZ20001394A3
公开(公告)日:2000-09-13
申请号:CZ20001394
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , GRIESGRABER GEORGE , LI LEPING , CHU DANIEL T
IPC: A61K31/7048 , A61P31/04 , C07H17/00 , C07H17/08
-
公开(公告)号:CA2263972A1
公开(公告)日:1998-03-12
申请号:CA2263972
申请日:1997-09-02
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , OR YAT SUN , CLARK RICHARD F , MA ZHENKUN , PLATTNER JACOB J , GRIESGRABER GEORGE
IPC: A61K31/70 , A61K31/7048 , A61P31/04 , C07H17/00 , C07H17/08
Abstract: Antimicrobial compounds having formula (II), (III), (IV), (IV-A) or (V) as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compunds.
-
公开(公告)号:CA2563965C
公开(公告)日:2009-08-25
申请号:CA2563965
申请日:1997-09-02
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , GRIESGRABER GEORGE , PLATTNER JACOB J , OR YAT SUN , MA ZHENKUN , CLARK RICHARD F
IPC: C07H17/08 , A61K31/351 , A61K31/7048 , A61P31/04 , C07D407/12
Abstract: Antimicrobial compounds having formula (II) as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds. (see formula II)
-
公开(公告)号:DE69734678T2
公开(公告)日:2006-08-17
申请号:DE69734678
申请日:1997-05-06
Applicant: ABBOTT LAB
Inventor: OR SUN , CLARK F , MA ZHENKUN , GRIESGRABER GEORGE , LI LEPING , CHU T
-
公开(公告)号:ES2252784T3
公开(公告)日:2006-05-16
申请号:ES97924605
申请日:1997-05-06
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , MA ZHENKUN , GRIESGRABER GEORGE , LI LEPING , CHU DANIEL T
Abstract: Un compuesto que tiene la fórmula o una sal farmacéuticamente aceptable del mismo, en la que X es =O, Ra es hidroxi; Rb es hidrógeno; Rc es hidrógeno y Rd es hidroxi; Re es metoxi; Rf es hidrógeno; y R se selecciona entre el grupo compuesto por (2) alquilo C2-C10 sustituido con uno o más sustituyentes seleccionados entre el grupo compuesto por (a) halógeno, (b) hidroxi, (c) alcoxi C1-C3, (d) alcoxi C1-C3-alcoxi C1-C3, (e) oxo, (f) -N3, (g) -CHO, (h) O-SO2-(alquilo C1-C6 sustituido), (i) -NR15R16 en la que R15 y R16 se seleccionan entre el grupo compuesto por (i) hidrógeno, (ii) alquilo C1-C12, (iii) alquilo C1-C12 sustituido, (iv) alquenilo C1-C12, (v) alquenilo C1-C12 sustituido, (vi) alquinilo C1-C12, (vii) alquinilo C1-C12 sustituido, (viii) arilo, (ix) cicloalquilo C3-C8, (x) cicloalquilo C3-C8 sustituido, (xi) arilo sustituido, (xii) heterocicloalquilo, (xiii) heterocicloalquilo sustituido, (xiv) alquilo C1-C12 sustituido con arilo, (xv) alquilo C1-C12 sustituido con arilo sustituido,(xvi) alquilo C1-C12 sustituido con heterocicloalquilo, (xvii) alquilo C1-C12 sustituido con sustituido heterocicloalquilo, (xviii) alquilo C1-C12 sustituido con cicloalquilo C3-C8, (xix) alquilo C1-C12 sustituido con cicloalquilo C3-C8 sustituido, (xx) heteroarilo, (xxi) sustituido heteroarilo, (xxii) alquilo C1-C12 sustituido con heteroarilo, y (xxiii) alquilo C1-C12 sustituido con heteroarilo sustituido, o R15 y R16 tomados junto con el átomo al que están unidos forman morfolinilo; (3) alquenilo C4-C10; y (4) alquinilo C3-C10.
-
公开(公告)号:DE69734678D1
公开(公告)日:2005-12-22
申请号:DE69734678
申请日:1997-05-06
Applicant: ABBOTT LAB
Inventor: OR SUN , CLARK F , MA ZHENKUN , GRIESGRABER GEORGE , LI LEPING , CHU T
-
公开(公告)号:ES2198766T3
公开(公告)日:2004-02-01
申请号:ES98956314
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , GRIESGRABER GEORGE , LI LEPING , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
公开(公告)号:PT1027361E
公开(公告)日:2003-09-30
申请号:PT98956314
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , LI LEPING , CHU DANIEL T , GRIESGRABER GEORGE
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
-
-
-
-
-
-
-
-